Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Am J Med Sci ; 308(2): 115-8, 1994 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8042652

RESUMO

Hypercalcemia associated with the extrarenal production of 1,25-dihydroxyvitamin D (1,25(OH)2D) has been reported in several disorders, most notably granulomatous diseases such as sarcoidosis. The authors describe a woman with hypercalcemia, renal insufficiency, microscopic hematuria, and anemia. The circulating 1,25(OH)2D level was higher than appropriate for the ambient conditions (renal insufficiency, suppressed intact parathyroid hormone, and hypercalcemia). A kidney biopsy was consistent with Wegener's granulomatosis, and treatment with prednisone and cyclophosphamide was associated with normalization of serum calcium levels, improved renal function, a marked decrease in serum 1,25(OH)2D levels, and increased serum intact parathyroid hormone levels. These findings are consistent with the unregulated production of 1,25(OH)2D by inflammatory cells associated with Wegener's granulomatosis.


Assuntos
Calcitriol/sangue , Granulomatose com Poliangiite/complicações , Hipercalcemia/etiologia , Idoso , Anemia/etiologia , Cálcio/sangue , Creatinina/sangue , Ciclofosfamida/uso terapêutico , Feminino , Granulomatose com Poliangiite/sangue , Granulomatose com Poliangiite/tratamento farmacológico , Hematúria/etiologia , Humanos , Hipercalcemia/sangue , Hipercalcemia/tratamento farmacológico , Hormônio Paratireóideo/sangue , Fósforo/sangue , Prednisona/uso terapêutico , Insuficiência Renal/etiologia , Albumina Sérica/análise
2.
J Endocrinol Invest ; 15(10): 771-5, 1992 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1491127

RESUMO

We describe an elderly man who presented with hypercalcemia associated with suppressed intact parathyroid hormone (PTH) levels. Despite renal insufficiency the circulating 1,25-dihydroxyvitamin D (1,25(OH)2D) was in the upper part of the normal range. Known causes of hypercalcemia were absent and mild hypercalcemia with suppression of intact PTH persisted until after bilateral hip replacement for severe arthritis (1 year after presentation). After hip replacement the ionized calcium normalized, intact PTH normalized, and 1,25(OH)2D decreased markedly. We believe the abnormalities in mineral homeostasis were related to production of 1,25(OH)2D by inflammatory mononuclear cells associated with arthritis.


Assuntos
Artrite/metabolismo , Di-Hidroxicolecalciferóis/metabolismo , Hipercalcemia/metabolismo , Idoso , Artrite/complicações , Prótese de Quadril , Humanos , Hipercalcemia/complicações , Masculino , Monócitos/metabolismo , Hormônio Paratireóideo/sangue
3.
J Clin Endocrinol Metab ; 54(5): 1039-44, 1982 May.
Artigo em Inglês | MEDLINE | ID: mdl-6977549

RESUMO

We studied the effects of glucocorticoid excess on calcium and phosphorus homeostasis in relation to vitamin D metabolites and parathyroid hormone (PTH) in seven patients with spontaneous ACTH-dependent Cushing's syndrome. Remission of hypercortisolism resulted in a significant increase in tubular reabsorption of phosphate [from 76 +/- 4% to 89 +/- 2% (mean +/- SEM); P less than 0.01] and serum phosphorus (from 3.1 +/- 0.1 to 4.2 +/- 0.2 mg/dl; P less than 0.005). Serum calcium did not change, although there was a reduction in daily urinary calcium excretion from 0.23 +/- 0.02 to 0.107 +/- 0.02 mg calcium/mg creatinine. Serum immunoreactive PTH (iPTH) levels were normal during Cushing's syndrome (34 +/- 5 microleq/ml), but fell significantly after remission to 22 +/- 2 microleq/ml (P less than 0.05). This small decrease in iPTH did not correlate with the improvement of phosphate homeostasis. Plasma 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D [1,25-(OH2)D] concentrations in Cushing's syndrome did not differ from measurements in 97 normal subjects. After treatment, 25OHD did not change, but 1,25-(OH)2D fell in each patient from a mean of 44 to 22 pg/ml (P less than 0.02). 1,25-(OH)2D was inversely correlated with serum phosphorus (r = 0.59; P less than 0.01), but did not correlate with iPTH. The known impairment of intestinal calcium absorption in Cushing's syndrome cannot be attributed to a decrease in the circulating levels of 1,25-(OH)2D. Endogenous hypercortisolism decreases tubular phosphate reabsorption and serum phosphorus, increase tubular phosphate reabsorption and serum phosphorus, increases iPTH, and results in an increase in 1,25-(OH)2D. These events may contribute to the severe loss of bone mass in such patients and may account for the calciuria and phosphaturia of Cushing's syndrome.


Assuntos
Cálcio/sangue , Síndrome de Cushing/sangue , Homeostase , Hormônio Paratireóideo/sangue , Fósforo/sangue , Vitamina D/sangue , 25-Hidroxivitamina D 2 , Adulto , Calcitriol/sangue , Ergocalciferóis/análogos & derivados , Ergocalciferóis/sangue , Feminino , Humanos , Masculino , Modelos Biológicos
4.
Am J Med ; 68(1): 154-6, 1980 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7188658

RESUMO

In a 56 year old woman, shock, disseminated intravascular coagulation, symmetrical peripheral gangrene and the adult respiratory distress syndrome developed following a dog bite. She suffered from chronic alcoholism and was asplenic. The newly described gram-negative bacillus (DF-2) was isolated from the initial blood cultures on the eighth hospital day when she was recovering from the illness. Penicillin G, clindamycin, or both (administered intravenously in large doses), and therapy directed toward the severe complications appeared responsible for her successful outcome.


Assuntos
Mordeduras e Picadas/complicações , Cães , Sepse/etiologia , Baço/fisiologia , Alcoolismo/complicações , Animais , Bactérias/isolamento & purificação , Clindamicina/uso terapêutico , Coagulação Intravascular Disseminada/etiologia , Feminino , Gangrena/etiologia , Humanos , Pessoa de Meia-Idade , Penicilina G/uso terapêutico , Síndrome do Desconforto Respiratório/etiologia , Sepse/tratamento farmacológico , Choque Séptico/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA